Data completeness
3/8 — Basic
ROBINUL (glycopyrrolate) by R-Pharm US is tissues, including salivary glands. Approved for neuromuscular blockade, chronic obstructive pulmonary disease, reversal of neuromuscular blockade and 8 more indications.
Drug data last refreshed 2w ago
Mechanism of Action
tissues, including salivary glands. Glycopyrrolate indirectly reduces the rate of salivation by preventing the stimulation of these receptors.
Worked on ROBINUL at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.